Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infiltrating Cervical Carcinoma”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Early research (Phase 1)Looking for participantsNCT06191133
What this trial is testing

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Who this might be right for
Cervical Intraepithelial NeoplasiaInvasive Cervical Cancer
Lindsay Ferguson, MD 24
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Not applicableNot Yet RecruitingNCT06412419
What this trial is testing

Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasms Malignant
Changhai Hospital 450
Not applicableUnknownNCT01487681
What this trial is testing

Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China

Who this might be right for
Human Papilloma VirusCervical CancerCervical Intraepithelial Neoplasia
Xing Xie, MD 4,000
Early research (Phase 1)UnknownNCT01462903
What this trial is testing

Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Nasopharyngeal CarcinomaHepatocellular CarcinomaBreast Carcinoma
Sun Yat-sen University 20
Early research (Phase 1)UnknownNCT04443296
What this trial is testing

Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Sun Yat-sen University 10
Not applicableActive Not RecruitingNCT06286462
What this trial is testing

Evaluation of the Cancer Tracking System (CATSystem)

Who this might be right for
Cervical Cancer
University of Kansas Medical Center 6,600
Testing effectiveness (Phase 2)UnknownNCT05342506
What this trial is testing

Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies

Who this might be right for
Cervical CancerOvarian CancerMalignant Trophoblastic Tumor
Peking Union Medical College Hospital 30
Not applicableUnknownNCT01074424
What this trial is testing

Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 84
Early research (Phase 1)Ended earlyNCT05035407
What this trial is testing

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Who this might be right for
Kita-kyushu Lung Cancer Antigen 1, Human
National Cancer Institute (NCI) 36
Not applicableEnded earlyNCT02767726
What this trial is testing

A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study

Who this might be right for
Women With Abnormal Pap Smears
Abramson Cancer Center at Penn Medicine 4
Testing effectiveness (Phase 2)Looking for participantsNCT06052839
What this trial is testing

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Dan Zandberg 15
Testing effectiveness (Phase 2)Looking for participantsNCT05639972
What this trial is testing

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Who this might be right for
HPV-Associated Cervical CarcinomaHPV-Related CarcinomaHPV-Related Malignancy+14 more
Christian Hinrichs 15
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Not applicableStudy completedNCT00458562
What this trial is testing

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Washington 1,680
Not applicableStudy completedNCT03920800
What this trial is testing

Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions

Who this might be right for
High-Grade Squamous Intraepithelial Lesions
Catherine Vanpachterbeke 100
Testing effectiveness (Phase 2)Looking for participantsNCT04114136
What this trial is testing

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Who this might be right for
MelanomaNSCLCHepatocellular Carcinoma+5 more
Dan Zandberg 72
Early research (Phase 1)Active Not RecruitingNCT05902520
What this trial is testing

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Who this might be right for
HNSCCMelanomaGynecologic Cancer+3 more
AgonOx, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT01585428
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Who this might be right for
Cervical CancerOropharyngeal CancerVaginal Cancer+2 more
National Cancer Institute (NCI) 29
Load More Results